• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补肺益肾方通过上调 ZNF263 和 Klotho 的表达抑制 COPD 细胞衰老。

Bufei Yishen Formula Inhibits the Cell Senescence in COPD by Up-Regulating the ZNF263 and Klotho Expression.

机构信息

Department of Gerontology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian, People's Republic of China.

Department of Respiratory Medicine, Huaian Hospital of Traditional Chinese Medicine, Affiliated to Nanjing University of Traditional Chinese Medicine, Huaian, People's Republic of China.

出版信息

Int J Chron Obstruct Pulmon Dis. 2023 Apr 8;18:533-539. doi: 10.2147/COPD.S383295. eCollection 2023.

DOI:10.2147/COPD.S383295
PMID:37065635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10094478/
Abstract

BACKGROUND

Bufei Yishen formula (BYF) is an effective prescription for the clinical treatment of chronic obstructive pulmonary disease (COPD). However, the molecular mechanism by which it exerts its pharmacological effects remains to be explored.

METHODS

The human bronchial cell line BEAS-2B was treated with cigarette smoke extract (CSE). Cellular senescence markers were detected by Western blot and ELISA. Potential transcription factor of klotho was predicted using JASPAR and USCS databases.

RESULTS

CSE induced cellular senescence with intracellular accumulation of cellular senescence biomarkers (p16, p21 and p27) and increased secretion of senescence-related secretory phenotypic (SASP) factors (IL-6, IL-8, and CCL3). In contrast, BYF treatment inhibited CSE-induced cellular senescence. CSE suppressed the transcription, expression and secretion of klotho, whereas BYF treatment rescued its transcription, expression and secretion. CSE downregulated the protein level of ZNF263, whereas BYF treatment rescued the expression of ZNF263. Furthermore, ZNF263-overexpressing BEAS-2B cells could inhibit CSE-induced cellular senescence and SASP factor secretion by upregulating the expression of klotho.

CONCLUSION

This study revealed a novel pharmacological mechanism by which BYF alleviates clinical symptoms of COPD patients, and regulating ZNF263 and klotho expression may be beneficial to the treatment and prevention of COPD.

摘要

背景

补肺益肾方(BYF)是治疗慢性阻塞性肺疾病(COPD)的有效方剂。然而,其发挥药理作用的分子机制仍有待探索。

方法

用香烟烟雾提取物(CSE)处理人支气管细胞系 BEAS-2B。通过 Western blot 和 ELISA 检测细胞衰老标志物。使用 JASPAR 和 USCS 数据库预测 klotho 的潜在转录因子。

结果

CSE 诱导细胞衰老,细胞内衰老生物标志物(p16、p21 和 p27)积累,衰老相关分泌表型(SASP)因子(IL-6、IL-8 和 CCL3)分泌增加。相反,BYF 处理抑制 CSE 诱导的细胞衰老。CSE 抑制 klotho 的转录、表达和分泌,而 BYF 处理挽救了其转录、表达和分泌。CSE 下调 ZNF263 的蛋白水平,而 BYF 处理挽救了 ZNF263 的表达。此外,过表达 ZNF263 的 BEAS-2B 细胞可以通过上调 klotho 的表达来抑制 CSE 诱导的细胞衰老和 SASP 因子分泌。

结论

本研究揭示了 BYF 缓解 COPD 患者临床症状的新的药理机制,调节 ZNF263 和 klotho 的表达可能有益于 COPD 的治疗和预防。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2108/10094478/ad67a42b4c57/COPD-18-533-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2108/10094478/7488475834f5/COPD-18-533-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2108/10094478/39bc53429023/COPD-18-533-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2108/10094478/ad67a42b4c57/COPD-18-533-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2108/10094478/7488475834f5/COPD-18-533-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2108/10094478/39bc53429023/COPD-18-533-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2108/10094478/ad67a42b4c57/COPD-18-533-g0003.jpg

相似文献

1
Bufei Yishen Formula Inhibits the Cell Senescence in COPD by Up-Regulating the ZNF263 and Klotho Expression.补肺益肾方通过上调 ZNF263 和 Klotho 的表达抑制 COPD 细胞衰老。
Int J Chron Obstruct Pulmon Dis. 2023 Apr 8;18:533-539. doi: 10.2147/COPD.S383295. eCollection 2023.
2
Effective-component compatibility of Bufei Yishen formula III ameliorated COPD by improving airway epithelial cell senescence by promoting mitophagy via the NRF2/PINK1 pathway.补肺益肾方 III 通过促进 NRF2/PINK1 通路介导的自噬来改善气道上皮细胞衰老,从而有效改善 COPD。
BMC Pulm Med. 2022 Nov 22;22(1):434. doi: 10.1186/s12890-022-02191-9.
3
Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling.补肺益肾方 II 的有效成分配伍通过调控 EGFR/PI3K/mTOR 信号通路抑制慢性阻塞性肺疾病大鼠的黏液高分泌
J Ethnopharmacol. 2020 Jul 15;257:112796. doi: 10.1016/j.jep.2020.112796. Epub 2020 Apr 25.
4
Restoring Th17/Treg balance via modulation of STAT3 and STAT5 activation contributes to the amelioration of chronic obstructive pulmonary disease by Bufei Yishen formula.通过调节 STAT3 和 STAT5 的激活来恢复 Th17/Treg 平衡有助于补肺益肾方改善慢性阻塞性肺疾病。
J Ethnopharmacol. 2018 May 10;217:152-162. doi: 10.1016/j.jep.2018.02.023. Epub 2018 Feb 16.
5
[Compatibility characteristics of Bufei Yishen formula III in regulating chronic obstructive pulmonary disease mucus hypersecretion].补肺益肾方Ⅲ调控慢性阻塞性肺疾病黏液高分泌的配伍特性
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Nov;33(11):1309-1314. doi: 10.3760/cma.j.cn121430-20210611-00868.
6
Effective-Component Compatibility of Bufei Yishen Formula III Suppresses Mitochondrial Oxidative Damage in COPD: Via Pkm2/Nrf2 Pathway.补肺益肾方 III 的有效成分配伍通过 Pkm2/Nrf2 通路抑制 COPD 模型大鼠的线粒体氧化损伤。
Int J Chron Obstruct Pulmon Dis. 2024 Aug 24;19:1905-1920. doi: 10.2147/COPD.S468825. eCollection 2024.
7
Bufei Yishen formula protects the airway epithelial barrier and ameliorates COPD by enhancing autophagy through the Sirt1/AMPK/Foxo3 signaling pathway.补肺益肾方通过Sirt1/AMPK/Foxo3信号通路增强自噬,保护气道上皮屏障并改善慢性阻塞性肺疾病。
Chin Med. 2024 Feb 28;19(1):32. doi: 10.1186/s13020-024-00905-1.
8
Maintenance of airway epithelial barrier integrity via the inhibition of AHR/EGFR activation ameliorates chronic obstructive pulmonary disease using effective-component combination.通过抑制 AHR/EGFR 激活来维持气道上皮屏障完整性可改善慢性阻塞性肺疾病,使用有效成分组合。
Phytomedicine. 2023 Sep;118:154980. doi: 10.1016/j.phymed.2023.154980. Epub 2023 Jul 17.
9
Resveratrol attenuates cigarette smoke extract induced cellular senescence in human airway epithelial cells by regulating the miR-34a/SIRT1/NF-κB pathway.白藜芦醇通过调控 miR-34a/SIRT1/NF-κB 通路减轻香烟烟雾提取物诱导的人气道上皮细胞衰老。
Medicine (Baltimore). 2022 Nov 18;101(46):e31944. doi: 10.1097/MD.0000000000031944.
10
Integration of transcriptomics, proteomics, metabolomics and systems pharmacology data to reveal the therapeutic mechanism underlying Chinese herbal Bufei Yishen formula for the treatment of chronic obstructive pulmonary disease.整合转录组学、蛋白质组学、代谢组学和系统药理学数据,揭示中药补肺益肾方治疗慢性阻塞性肺疾病的治疗机制。
Mol Med Rep. 2018 Apr;17(4):5247-5257. doi: 10.3892/mmr.2018.8480. Epub 2018 Jan 25.

引用本文的文献

1
An Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometric Method for the Simultaneous Determination of Eighteen Marker Compounds in the Traditional Herbal Formula Bopyeo-Tang.一种同时测定传统中药补阳汤中18种标志物化合物的超高效液相色谱-串联质谱法。
Pharmaceuticals (Basel). 2024 Mar 8;17(3):352. doi: 10.3390/ph17030352.

本文引用的文献

1
Identification of cancer risk assessment signature in patients with chronic obstructive pulmonary disease and exploration of the potential key genes.鉴定慢性阻塞性肺疾病患者的癌症风险评估特征,并探索潜在的关键基因。
Ann Med. 2022 Dec;54(1):2309-2320. doi: 10.1080/07853890.2022.2112070.
2
Effective-Component Compatibility of Bufei Yishen Formula III Combined with Electroacupuncture Suppresses Inflammatory Response in Rats with Chronic Obstructive Pulmonary Disease via Regulating SIRT1/NF-B Signaling.补肺益肾方 III 联合电针对慢性阻塞性肺疾病大鼠炎症反应的抑制作用及其调控 SIRT1/NF-κB 信号通路的研究
Biomed Res Int. 2022 May 9;2022:3360771. doi: 10.1155/2022/3360771. eCollection 2022.
3
Chronic Obstructive Pulmonary Disease Treatment and Pharmacist-Led Medication Management.
慢性阻塞性肺疾病的治疗和药剂师主导的药物管理。
Drug Des Devel Ther. 2021 Jan 12;15:111-124. doi: 10.2147/DDDT.S286315. eCollection 2021.
4
Mechanism of Action of Bu-Fei-Yi-Shen Formula in Treating Chronic Obstructive Pulmonary Disease Based on Network Pharmacology Analysis and Molecular Docking Validation.基于网络药理学分析和分子对接验证的补肺益肾方治疗慢性阻塞性肺疾病的作用机制。
Biomed Res Int. 2020 Nov 26;2020:9105972. doi: 10.1155/2020/9105972. eCollection 2020.
5
Tiotropium/Olodaterol treatment reduces cigarette smoke extract-induced cell death in BEAS-2B bronchial epithelial cells.噻托溴铵/奥达特罗治疗可减少香烟烟雾提取物诱导的BEAS-2B支气管上皮细胞死亡。
BMC Pharmacol Toxicol. 2020 Oct 31;21(1):74. doi: 10.1186/s40360-020-00451-0.
6
Diagnosis and Treatment of Early Chronic Obstructive Lung Disease (COPD).早期慢性阻塞性肺疾病(COPD)的诊断与治疗
J Clin Med. 2020 Oct 26;9(11):3426. doi: 10.3390/jcm9113426.
7
Bufei Yishen Formula Restores Th17/Treg Balance and Attenuates Chronic Obstructive Pulmonary Disease Activation of the Adenosine 2a Receptor.补肺益肾方恢复Th17/Treg平衡并减轻慢性阻塞性肺疾病中腺苷2a受体的激活。
Front Pharmacol. 2020 Aug 7;11:1212. doi: 10.3389/fphar.2020.01212. eCollection 2020.
8
Alantolactone suppresses inflammation, apoptosis and oxidative stress in cigarette smoke-induced human bronchial epithelial cells through activation of Nrf2/HO-1 and inhibition of the NF-κB pathways.土木香内酯通过激活 Nrf2/HO-1 通路和抑制 NF-κB 通路抑制香烟烟雾诱导的人支气管上皮细胞的炎症、凋亡和氧化应激。
Respir Res. 2020 Apr 22;21(1):95. doi: 10.1186/s12931-020-01358-4.
9
A miRNA's insight into the regenerating heart: a concise descriptive analysis.miRNA 对心脏再生的洞察:简明描述性分析。
Heart Fail Rev. 2020 Nov;25(6):1047-1061. doi: 10.1007/s10741-019-09896-w.
10
Single-Cell Transcriptome Analysis of Uniparental Embryos Reveals Parent-of-Origin Effects on Human Preimplantation Development.单细胞转录组分析揭示了单亲胚胎对人类胚胎着床前发育的母源效应。
Cell Stem Cell. 2019 Nov 7;25(5):697-712.e6. doi: 10.1016/j.stem.2019.09.004. Epub 2019 Oct 3.